Ascentage Pharma Group International Adr (AAPG)

Feb 11, 2026

Rodman & Renshaw Initiates Ascentage Pharma Group International (AAPG) with Buy Rating, $48 Target - Finviz

Feb 11, 2026

Feb 09, 2026

Ascentage Pharma to Present at Guggenheim Biotech Summit as Late-Stage Oncology Pipeline Expands - TipRanks

Feb 09, 2026

Feb 08, 2026

Ascentage Pharma Group InternationalUnsponsored ADR (NASDAQ:AAPG) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Feb 08, 2026

Feb 06, 2026

Ascentage Pharma Wins China IND Clearance for Next-Gen BTK Degrader APG-3288 - TipRanks

Feb 06, 2026

Feb 05, 2026

Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - GlobeNewswire Inc.

Feb 05, 2026

Feb 05, 2026

Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - Sahm

Feb 05, 2026

Feb 05, 2026

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap UpTime to Buy? - MarketBeat

Feb 05, 2026

Jan 30, 2026

Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume IncreaseTime to Buy? - MarketBeat

Jan 30, 2026

Jan 30, 2026

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Sees Significant Increase in Short Interest - Defense World

Jan 30, 2026

Jan 21, 2026

Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap DownWhat's Next? - MarketBeat

Jan 21, 2026

Jan 17, 2026

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Short Interest Update - Defense World

Jan 17, 2026

Jan 15, 2026

Ascentage Pharma Details 2026 Global Innovation Strategy at J.P. Morgan Healthcare Conference - TipRanks

Jan 15, 2026

Jan 14, 2026

Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference - Sahm

Jan 14, 2026

Jan 14, 2026

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Jan 14, 2026

Jan 08, 2026

Analysts Offer Insights on Healthcare Companies: BeOne Medicines (ONC) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail

Jan 08, 2026

Jan 07, 2026

Ascentage Pharma Wins FDA IND Clearance for BTK Degrader APG-3288 to Enter Global Phase I Trial - TipRanks

Jan 07, 2026

Jan 06, 2026

Ascentage Pharma Announces IND Clearance by the U.S. Food and Drug Administration for BTK Degrader APG-3288 - Sahm

Jan 06, 2026

Dec 23, 2025

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Receives $48.50 Average Price Target from Brokerages - Defense World

Dec 23, 2025

Dec 22, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 5.5%Should You Sell? - MarketBeat

Dec 22, 2025

Dec 17, 2025

Ascentage Pharma to Present at J.P. Morgan Healthcare Conference - TipRanks

Dec 17, 2025

Dec 16, 2025

Ascentage Pharma to Engage Investors at December 2025 Conferences - MSN

Dec 16, 2025

Dec 10, 2025

Ascentage Pharma Showcases Promising Data for Olverembatinib at ASH 2025 - The Globe and Mail

Dec 10, 2025

Dec 09, 2025

Ascentage Pharma showcases promising data for olverembatinib at ASH 2025 - MSN

Dec 09, 2025

Dec 08, 2025

Ascentage Pharma Unveils Promising Lisaftoclax Data at ASH 2025 - TipRanks

Dec 08, 2025

Dec 05, 2025

Cash per share of Ascentage Pharma Group International Unsponsored ADR – LSX:A40ZYR - TradingView

Dec 05, 2025

Dec 05, 2025

ETFs Investing in Ascentage Pharma Group International Unsponsored ADR Stocks - TradingView — Track All Markets

Dec 05, 2025

Dec 05, 2025

Cash per share of Ascentage Pharma Group International Unsponsored ADR – LS:A40ZYR - TradingView

Dec 05, 2025

Dec 01, 2025

Ascentage Pharma to Highlight Key Data from ASH 2025 in Upcoming Webcast - TipRanks

Dec 01, 2025

Nov 28, 2025

Ascentage Pharma Announces New RSU and Share Option Grants - TipRanks

Nov 28, 2025

Nov 26, 2025

Analysts’ Top Healthcare Picks: Amgen (AMGN), Opus Genetics (IRD) - The Globe and Mail

Nov 26, 2025

Nov 25, 2025

Ascentage Pharma’s Olverembatinib Shows Promise in Rare GIST Treatment - TipRanks

Nov 25, 2025

Nov 25, 2025

Ascentage Pharma Group International (NASDAQ:AAPG) Now Covered by Analysts at Truist Financial - Defense World

Nov 25, 2025